Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | THRA | P10827 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SHBG | P04278 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27887291 | 0.98 | CA2 (0.52) | CA2CA1ALDH1A1HSD17B10HPGD | |
| SCHEMBL27862855 | 0.93 | RARB (0.56) | CA2CA1ALDH1A1HSD17B10HPGD | |
| SCHEMBL1101345 | 0.93 | ESR1 (0.59) | CA2ALDH1A1HSD17B10ESR1ADRA2A | |
| Magnesium Chloride Anhydrous SCHEMBL27534583 | 0.91 | HTR2A (0.48) | CA2CA1ALDH1A1HSD17B10HPGD | |
| SCHEMBL23755035 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL7335623 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL23754712 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL1119534 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL7929651 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL1006220 | 0.91 | ESR1 (0.63) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106588696-A | Preparation method of trans-alpha, beta-unsaturated nitriles compound | 西北师范大学 | 2017-04-26 | — | — | CN | claimed |
| US-20150232420-A1 | TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | EVOTEC (UK) LTD. (GB) | 2015-08-20 | — | — | US | claimed |
| EP-2486005-B1 | PYRROLIDINE GPR40 MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2014-06-18 | — | — | EP | claimed |
| US-8288404-B2 | Pyrrolidine GPR40 modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-10-16 | — | — | US | claimed |
| EP-2486005-A1 | PYRROLIDINE GPR40 MODULATORS | Bristol-Myers Squibb Company (US) | 2012-08-15 | — | — | EP | claimed |
| CN-102584829-A | Pyrazole and pyrazine diketone derivative and application thereof | UNIV SHANDONG | 2012-07-18 | — | — | CN | claimed |
| US-7947837-B2 | dimeric and polymeric compounds based upon fused ring tetracarboxylic imides, used as electronic thin films on substrates; transistors | POLYERA CORPORATION (US) | 2011-05-24 | — | — | US | claimed |
| WO-2011044073-A1 | PYRROLIDINE GPR40 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-04-14 | — | — | WO | claimed |
| US-20110082165-A1 | PYRROLIDINE GPR40 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2011-04-07 | — | — | US | claimed |
| CN-101367819-B | 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof | UNIV SHANDONG | 2010-08-18 | — | — | CN | claimed |
| EP-1307198-A1 | PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE | HANWHA CHEMICAL CORPORATION (KR) | 2003-05-07 | — | — | EP | claimed |
| US-6410497-B1 | DETERGENTS; BLEACHES; ANTISEPTICS | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | claimed |
| US-20020052501-A1 | 4-cyanocoumarin derivatives and uses thereof | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2002-05-02 | — | — | US | claimed |
| WO-2001095908-A1 | PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE | HANWHA CHEMICAL CORPORATION (KR) | 2001-12-20 | — | — | WO | claimed |
| EP-1041074-A1 | Light-sensitive 4-cyanocoumarin derivatives | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2000-10-04 | — | — | EP | claimed |
| US-5510519-A | OPTICAL RESOLUTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-04-23 | — | — | US | claimed |
| EP-0508307-B1 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL CO (JP) | 1995-11-29 | — | — | EP | claimed |
| US-5298660-A | Compound containing an assymetrical carbon atom | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0508307-A2 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-10-14 | — | — | EP | claimed |
| US-4681699-A | Bisazo dyes and their use in liquid crystalline materials | BASF AKTIENGESELLSCHAFT (DE) | 1987-07-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232420-A1 | TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | HTT, TGM2, GRN | CA2 478/4885CA1 475/4885ALDH1A1 3161/4885 |
| US-20020052501-A1 | 4-cyanocoumarin derivatives and uses thereof | CACYBP, CYBA, IK | CA2 548/4885CA1 1817/4885ALDH1A1 1333/4885 |
| US-20110082165-A1 | PYRROLIDINE GPR40 MODULATORS | GPR55, GPR65, GPR27 | CA2 1527/4885CA1 4429/4885ALDH1A1 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.